The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)

Investment Considerations Scinai has an exclusive worldwide license to commercialize inhalable NanoAbs for the treatment of COVID-19. The inhaled NanoAbs led to shorter and milder illness, and protected against illness, in vivo. Scinai has exclusive options for worldwide licenses for NanoAbs to treat other disorders with large, underserved needs, including psoriasis. The company further hedges … Continue reading “Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)”

View Profile